Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

4/26/2013, Friday

Former Executive Director, Department of Defense and Department of Veterans Affairs Vision Center of Excellence, Joins Bausch + Lomb

Donald Gagliano, M.D., Appointed Vice President, Global Development Operations

ROCHESTER, NY — Bausch + Lomb, the global eye health company, today announced that Colonel Donald Gagliano, M.D., has joined the company as vice president, global development operations. Dr. Gagliano will lead the scientific review of global business development opportunities and strategic initiatives for the company’s Pharmaceuticals business, as well as support special projects in its Surgical business.   

“Dr. Gagliano brings to Bausch + Lomb a long record of distinctive accomplishment in the global eye health community,” said Dan Wechsler, executive vice president and president, Bausch + Lomb Global Pharmaceuticals. “He will play a leading role as we continue to develop and deliver innovative solutions to physicians and their patients in markets around the world.”

A retinal ophthalmologist and a fellow of the American College of Health Care Executives, Dr. Gagliano has served since 2008 as executive director, Department of Defense (DoD)/Department of Veterans Affairs (VA) Vision Center of Excellence (VCE), in Bethesda, Maryland. He established and led this Congressionally-mandated center of excellence to be the nation’s leader in the prevention, clinical care, research, education, advocacy and information management for military eye injuries and diseases and vision disorders with traumatic brain injury across the DoD and VA continuum. In February 2013, the VCE was recognized by the Foundation for Fighting Blindness with the 2013 Innovators Award.

In a prior appointment, Dr. Gagliano served as director of the clinical investigations regulatory office in the army medical research and materiel command. He directed a designated federal laboratory responsible for regulatory oversight and compliance of the army clinical investigation program and clinical collaborative research and development agreements. Earlier, Dr Gagliano served as chairman of the medical education and training campus executive committee, U.S. army medical department center and school in San Antonio.           

Over a military career spanning more than 30 years, Dr. Gagliano has led soldiers at every level of command, including the 30th medical brigade in Iraq from February 2003 until February 2004. Under his command, the 30th medical brigade was awarded the meritorious unit citation for exemplary performance. Since 1998, he has served as a clinical adjunct professor of surgery, Uniformed Services University of Health Sciences, in Bethesda, Maryland. 

“I have dedicated my entire career to helping protect, enhance and restore the gift of sight for our country’s service men and women,” said Dr. Gagliano. “I’m thrilled to continue and expand upon this important work by joining a company who shares my commitment and vision.”

About Bausch + Lomb 
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments. We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.

®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates.
All other band/product names are trademarks of their respective owners.
© 2013 Bausch & Lomb Incorporated.

# # #

News Media Contacts
Teresa Panas
Global Pharmaceutical Communicatons, Bausch + Lomb
(973)-360-6382 or

Tad Heitmann
BioComm Network on behalf of Bausch + Lomb
(714) 273-2937 or


Number of views (2641)/Comments (0)